![Sin imagen](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 2162134-62-3
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | Garadacimab REF: TM-T77018CAS: 2162134-62-3 | SDS-PAGE:95% SEC-HPLC:99.99% | 291,00 €~2.471,00 € | Vie 19 Jul 24 |
![]() | Garadacimab REF: 3D-CLA1563CAS: 2162134-62-3 | - - - | A consultar | Lun 29 Jul 24 |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Garadacimab
CAS:2162134-62-3
Garadacimab (CSL312) is a human IgG4 antibody against FXIIa, used to research hereditary angioedema.
Pureza:
SDS-PAGE:95% SEC-HPLC:99.99%
Forma y color:
Solid
Ref: TM-T77018
1mg | 291,00 € | ||
5mg | 601,00 € | ||
10mg | 916,00 € | ||
25mg | 1.356,00 € | ||
50mg | 1.830,00 € | ||
100mg | 2.471,00 € |
Entrega estimada en Estados Unidos, el Viernes 19 de Julio de 2024
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Garadacimab
CAS:2162134-62-3
Humanized IgG4 monoclonal antibody targeting activated factor XII (FXIIa).
Ref: 3D-CLA1563
Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Lunes 29 de Julio de 2024